NASDAQ:VALN Valneva (VALN) News Today $12.55 -0.22 (-1.72%) (As of 09:30 AM ET) Add Compare Share Share Today's Range$12.55▼$12.5550-Day Range$12.52▼$15.6352-Week Range$9.07▼$17.05Volume1,799 shsAverage Volume7,309 shsMarket Capitalization$871.72 millionP/E Ratio89.64Dividend YieldN/APrice Target$22.00 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineValneva receives JE vaccine supply contract from US DoDmsn.com - September 25 at 8:35 AMValneva gets new $32M supply contract for the U.S. governmentmsn.com - September 25 at 3:35 AMValneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32 Millionfinance.yahoo.com - September 25 at 3:35 AMU.S. FDA found lapses at Novo's main U.S. factory in May 2022 -reportmsn.com - September 21 at 1:20 PMValneva Reports Half Year 2023 Financial Results and Provides Corporate Updatesmarkets.businessinsider.com - September 21 at 8:20 AMValneva Loss Narrows on Reduced Costsmarketwatch.com - September 21 at 8:20 AMValneva's half-year loss narrows on strong travel vaccine demandmsn.com - September 21 at 8:20 AMValneva Reports Half Year 2023 Financial Results and Provides Corporate Updatesfinance.yahoo.com - September 21 at 8:20 AMPfizer Lyme Disease Vaccine Shows Promisemsn.com - September 8 at 5:49 AMAnalyst Ratings for Valnevamarkets.businessinsider.com - September 7 at 5:09 PMValneva Reports Positive Pediatric & Adolescent Phase 2 Booster Results For Lyme Disease Vaccinemarkets.businessinsider.com - September 7 at 4:41 AMVALNEVA Declaration of shares and voting rights: August 31, 2023finance.yahoo.com - September 6 at 3:02 AMValneva to Participate in Investor Conferences in the United States and Europe in September 2023finance.yahoo.com - August 31 at 7:22 PMHealth Canada accepts Valneva’s chikungunya vaccine filing for reviewmsn.com - August 29 at 11:17 PMCanada Accepts Valneva's Chikungunya Vaccine License Application For Reviewmarkets.businessinsider.com - August 29 at 7:40 AMHealth Canada Accepts Valneva's Chikungunya Vaccine License Application for Reviewtmcnet.com - August 29 at 2:40 AMHealth Canada Accepts Valneva’s Chikungunya Vaccine License Application for Reviewfinance.yahoo.com - August 29 at 2:40 AMVALNEVA: Valneva Reports Positive Initial Phase 3 Safety Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidatefinanznachrichten.de - August 28 at 6:38 AMValneva Reports Positive Safety Data In Adolescents For Chikungunya Vaccine Candidatemarkets.businessinsider.com - August 28 at 6:38 AMValneva Gets Positive Data in Chikungunya Vaccine Trialmarketwatch.com - August 28 at 6:38 AMValneva reports data from chikungunya vaccine trial in adolescentsmsn.com - August 28 at 6:38 AMValneva Reports Positive Initial Phase 3 Safety Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidatefinance.yahoo.com - August 28 at 6:38 AMNorthX Biologics Welcomes Dr Janet Hoogstraate as New CEO Following Merger with Valneva Clinical Trials Manufacturing Unitbenzinga.com - August 23 at 5:26 AMValneva to Get Up to $100 Mln in Funding for Research, Chikungunya Vaccinemarketwatch.com - August 17 at 6:48 AMValneva Announces Extension of Existing Loan Agreementfinance.yahoo.com - August 17 at 1:47 AMValneva pushes FDA approval date for chikungunya vaccinemsn.com - August 15 at 6:09 PMValneva falls as FDA extends review of chikungunya vaccineseekingalpha.com - August 14 at 3:42 PMValneva Says FDA Has Delayed Chikungunya Vaccine Review Datemarketwatch.com - August 14 at 4:48 AMFDA Extends PDUFA Date For Valneva's Chikungunya Virus Vaccine Candidatemarkets.businessinsider.com - August 14 at 4:48 AMValneva Shares Slump After FDA Postpones Chikungunya Vaccine Review Datemarketwatch.com - August 14 at 4:48 AMValneva Announces PDUFA Date Extension for Chikungunya Virus Vaccine Candidatefinance.yahoo.com - August 14 at 4:48 AMBella Hadid opens up about her journey with Lyme diseasemsn.com - August 6 at 4:08 PMVALNEVA Declaration of shares and voting rights - July 31, 2023finance.yahoo.com - August 3 at 8:14 AMValneva SE (INRLF) Price Target Increased by 8.92% to 11.20msn.com - August 2 at 8:15 PMVBI Vaccines Announces PreHevbri® is Now Available in the Netherlands and Belgium for the Prevention of Hepatitis B in Adultsfinance.yahoo.com - July 19 at 9:28 AMValneva: VLA1553 Takes The Lead In The Chikungunya Vaccine Raceseekingalpha.com - July 18 at 4:17 AMNJ Lyme disease cases rising. Could this vaccine kill it for good?msn.com - July 7 at 8:58 AMWould you volunteer your kid to test a Lyme disease vaccine? Here's why some parents willmsn.com - July 6 at 9:16 AMVALNEVA - Declaration of shares and voting rights: June 30, 2023finance.yahoo.com - July 5 at 9:02 AMNorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valnevatechnews.tmcnet.com - July 3 at 8:58 AMA woman is trying out a 4-dose Lyme disease vaccine as we approach the worst summer for ticks yetnews.yahoo.com - June 27 at 8:03 PMAccor Share Price: This French Stock Received an Upgraded Ratingmarkets.businessinsider.com - June 25 at 7:58 AMWorst of Westminster: Labour Lords U-turn and interest rates hikeuk.news.yahoo.com - June 23 at 12:53 PMValneva Announces Successful Outcome of its AGM and the Appointment of Pfizer's Former Vaccine R&D Head to its Supervisory Boardmarketwatch.com - June 22 at 3:48 PMVALNEVA: Valneva Supervisory Board Recommends Transition from a Two-Tier Governance Model to a Board of Directorsfinanznachrichten.de - June 22 at 9:38 AMVALNEVA: Valneva Announces Successful Outcome of its AGM and the Appointment of Pfizer's Former Vaccine R&D Head to its Supervisory Boardfinanznachrichten.de - June 22 at 9:38 AMValneva Supervisory Board Recommends Transition from a Two-Tier Governance Model to a Board of Directorsfinance.yahoo.com - June 22 at 9:38 AMCancelled Covid-19 vaccine made in Scotland cost taxpayers £358mthetimes.co.uk - June 21 at 11:20 PMAxed Livingston Covid vaccine contract cost taxpayers £358millionmsn.com - June 21 at 1:19 PMStrength Seen in Valneva SE Sponsored ADR (VALN): Can Its 15.8% Jump Turn into More Strength?finance.yahoo.com - June 21 at 1:19 PM Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address VALN Media Mentions By Week VALN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼-0.250.51▲Average Medical News Sentiment VALN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼102▲VALN Articles Average Week Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INBX News AXLA News SANA News IMTX News ADMA News IBRX News RGNX News ADPT News KYMR News REPL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:VALN) was last updated on 9/25/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.